Jia Yueting: $30 million investment in Qualigen Therapeutics will be completed this week

Faraday Future founder Jia Yueting wrote that Faraday Future's $30 million investment in Qualigen Therapeutics (QLGN) has more than doubled its market value. The strategic investment is expected to be completed this week, and the encryption flywheel is accelerating.